ZYMO PHARMACEUTICALS

Serial Number 85645657
603

Registration Progress

Application Filed
Jun 7, 2012
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

ZYMO PHARMACEUTICALS

Basic Information

Serial Number
85645657
Filing Date
June 7, 2012
Abandonment Date
December 1, 2014
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
603
Status Date
Dec 1, 2014
Classes
005

Rights Holder

Zymo Research Corp.

03
Address
17062 Murphy Aveenue
Irvine, CA 92614

Ownership History

Zymo Research Corp.

Original Applicant
03
Irvine, CA

Legal Representation

Attorney
Jonathan A. Claypool

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

31 events
Date Code Type Description Documents
Dec 1, 2014 EXPT T EXPARTE APPEAL TERMINATED Loading...
Dec 1, 2014 ABN3 O ABANDONMENT - AFTER EX PARTE APPEAL Loading...
Dec 1, 2014 MAB3 O ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL Loading...
Oct 20, 2014 EXFB T EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF Loading...
Aug 1, 2014 CNCF S ACTION CONTINUING FINAL - COMPLETED Loading...
Aug 1, 2014 GECD O ACTION DENYING REQ FOR RECON E-MAILED Loading...
Aug 1, 2014 GEA1 O NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED Loading...
Jul 15, 2014 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 15, 2014 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 8, 2014 EXAF T EXPARTE APPEAL RECEIVED AT TTAB Loading...
Jul 8, 2014 JURT T JURISDICTION RESTORED TO EXAMINING ATTORNEY Loading...
Jul 8, 2014 EXPI T EX PARTE APPEAL-INSTITUTED Loading...
Jul 8, 2014 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Jan 9, 2014 CNFR R FINAL REFUSAL WRITTEN Loading...
Jan 9, 2014 GNFR O FINAL REFUSAL E-MAILED Loading...
Jan 9, 2014 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Oct 3, 2013 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Apr 3, 2013 ALIE A ASSIGNED TO LIE Loading...
Apr 3, 2013 DMCC I DATA MODIFICATION COMPLETED Loading...
Apr 2, 2013 CNSL R SUSPENSION LETTER WRITTEN Loading...
Apr 2, 2013 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Apr 2, 2013 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Apr 1, 2013 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 31, 2013 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 31, 2013 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 30, 2012 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 30, 2012 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 30, 2012 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 22, 2012 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 18, 2012 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 11, 2012 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARMACEUTICALS"